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Abstract. 
 
The yeast 
 
a
 
-factor receptor (encoded by 
 
STE3
 
) is subject to two modes of endocytosis, a ligand-
dependent endocytosis as well as a constitutive, ligand-
independent mode. Both modes are associated with re-
ceptor ubiquitination (Roth, A.F., and N.G. Davis. 
1996. 
 
J. Cell Biol.
 
 134:661–674) and both depend on se-
quence elements within the receptor’s regulatory, cyto-
plasmically disposed, COOH-terminal domain (CTD). 
Here, we concentrate on the Ste3p sequences required 
for constitutive endocytosis. Constitutive endocytosis is 
rapid. Receptor is synthesized, delivered to the cell sur-
face, endocytosed, and then delivered to the vacuole 
where it is degraded, all with a 
 
t
 
1/2
 
 of 15 min. Deletion 
analysis has defined a 36-residue-long sequence map-
ping near the COOH-terminal end of the Ste3p CTD 
that is the minimal sequence required for this rapid 
turnover. Deletions intruding into this interval block or 
severely slow the rate of endocytic turnover. Moreover, 
the same 36-residue sequence directs receptor ubiquiti-
nation. Mutants deleted for this sequence show unde-
tectable levels of ubiquitination, and mutants having in-
termediate endocytosis defects show a correlated 
reduced level of ubiquitination. Not only necessary for 
ubiquitination and endocytosis, this sequence also is 
sufficient. When transplanted to a stable cell surface 
protein, the plasma membrane ATPase Pma1p, the 36-
residue STE3 signal directs both ubiquitination of the 
PMA1-STE3 fusion protein as well as its endocytosis 
and consequent vacuolar degradation. Alanine scan-
ning mutagenesis across the 36-residue-long interval 
highlights its overall complexity—no singular sequence 
motif or signal is found, instead required sequence ele-
ments distribute throughout the entire interval. The 
high proportion of acidic and hydroxylated amino acid 
residues in this interval suggests a similarity to PEST 
sequences—a broad class of sequences which have 
been shown to direct the ubiquitination and subsequent 
proteosomal degradation of short-lived nuclear and 
cytoplasmic proteins. A likely possibility, therefore, is 
that this sequence, responsible for both endocytosis and 
ubiquitination, may be first and foremost a ubiquitina-
tion signal. Finally, we present evidence suggesting that 
the true signal in the wild-type receptor extends beyond 
the 36-residue-long sequence defined as a minimal sig-
nal to include contiguous PEST-like sequences which 
extend another 21 residues to the COOH terminus of 
Ste3p. Together with sequences identified in two other 
yeast plasma membrane proteins, the STE3 sequence 
defines a new class of ubiquitination/endocytosis signal.
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I
 
n
 
 mammalian cells, the events surrounding the initial
cell surface capture of membrane proteins by recep-
tor-mediated endocytosis are reasonably well under-
stood (Mellman, 1996; Schmid, 1997). The process is se-
lective with proteins destined for uptake being first
sequestered into differentiated subdomains of the plasma
membrane, i.e., clathrin-coated pits. Pits invaginate, pinch-
ing off as clathrin-coated membrane vesicles into the cyto-
plasm. Uptake selectivity is controlled through a specific
binding interaction between the endocytosis signal, a pep-
tidyl sequence localized to the cytoplasmically exposed
domains of the membrane protein, and the adaptin com-
plex, a component of the coated pit. Two varieties of such
endocytosis signals have so far been identified. Y-based
signals constitute a loosely conserved motif in which an ar-
omatic residue, either tyrosine or phenylalanine plays a
central role. L-based signals have a leucine–leucine dipep-
tide as the central recognizable feature. For both, the func-
 
Address all correspondence to N.G. Davis, Departments of Surgery and
Pharmacology, Wayne State University School of Medicine, Elliman
Building, room 1205, 421 E. Canfield, Detroit, MI 48201. Tel.: (313) 577-
7807. Fax: (313) 577-7642. E-mail: ndavis@cmb.biosci.wayne.edu
  
The Journal of Cell Biology, Volume 142, 1998 950
 
tional signal is short and discrete, lying within a polypep-
tide sequence 5–10 residues long.
In the yeast 
 
Saccharomyces cerevisiae
 
, much progress has
been made in recent years in understanding endocytic pro-
cesses. Genetic analyses have identified a large collection of
cellular proteins that participate in this process, both at the
initial plasma membrane uptake step as well as at the subse-
quent endosomal transport steps (Riezman et al., 1996). In
spite of the wealth of genetic data, the molecular details of
the initial cell surface uptake event remain surprisingly ob-
scure. As for mammalian cells, the process is selective—
only a subset of the plasma membrane proteins are subject
to endocytosis, others, for instance, the plasma membrane
ATPase, Pma1p, remain stably at the cell surface (Benito et
al., 1991). Although clear homologues of the mammalian
clathrin and adaptins have been identified, their direct in-
volvement in this uptake remains uncertain. Mutants gener-
ated in the gene for the yeast clathrin heavy chain slow, yet
do not block endocytic uptake (Payne et al., 1988; Tan et al.,
1993). Much more profound effects are seen instead for mu-
tants that disrupt the yeast cell’s actin cytoskeleton. Mu-
tants in actin, myosin, as well as in a variety of actin-associ-
ated proteins often lead to a near total block of the uptake
process (Riezman et al., 1996).
Protein ubiquitination has also emerged as a regulator
of initial endocytic uptake events both in yeast (Kolling
and Hollenberg, 1994; Egner and Kuchler, 1996; Galan et al.,
1996; Hicke and Riezman, 1996; Roth and Davis, 1996;
Galan and Haguenauer-Tsapis, 1997; Kolling and Losko,
1997; Marchal et al., 1998) and in mammalian cells (Strous
et al., 1996; Gowers et al., 1997). Ubiquitin, a small 76-res-
idue protein, has long been known as a regulator of pro-
tein degradation in the cell cytoplasm. Covalent attach-
ment of ubiquitin to selected lysyl residues targets the
substrate protein for proteosomal degradation (Hoch-
strasser, 1996). The degradative turnover of plasma mem-
brane proteins or of proteins that enter the cell via the en-
docytic route has generally been thought to involve a
separate system, that being proteolysis by the proteases re-
siding within the membrane-enclosed space of the lyso-
some. Nevertheless, for a number of years, a growing col-
lection of mammalian cell surface proteins have found to
have covalently attached ubiquitin (Ciechanover, 1994).
Recently, these findings have been mirrored by similar
findings in yeast where a number of different plasma
membrane proteins have been found to be ubiquitinated.
In yeast, studies designed to test the function of the ubiq-
uitin modification draw a consistent picture, linking ubiq-
uitination to endocytosis (Kolling and Hollenberg, 1994;
Egner and Kuchler, 1996; Galan et al., 1996; Hicke and
Riezman, 1996; Roth and Davis, 1996; Kolling and Losko,
1997; Galan and Haguenauer-Tsapis, 1997; Marchal et al.,
1998). The general model that has emerged has ubiquitin
attached to cytoplasmic portions of surface membrane
proteins serving as a flag, signaling uptake. Strong support
for this model comes from work on the 
 
a
 
-factor receptor,
one of the two pheromone receptors in yeast. In a first re-
port, mutation of the presumptive lysyl ubiquitin acceptor
site concomitantly abolished both ubiquitination and up-
take (Hicke and Riezman, 1996) indicating a requirement
for ubiquitination in endocytosis. In a second report, ubiq-
uitin addition was found to provide a sufficient trigger for
uptake: a translational in-frame fusion of a ubiquitin moi-
ety to the cytoplasmic domain of an endocytosis-defective
mutant 
 
a
 
-factor receptor restored endocytic capacity (Ter-
rell et al., 1998). Furthermore, the results of Terrell et al.
(1998) also indicate a fundamental point of difference be-
tween ubiquitin’s involvement in proteosomal degradation
versus endocytosis. Whereas proteosomal recognition gen-
erally requires the elaboration of a multi-ubiquitin chain
on the substrate protein (Hochstrasser, 1996), addition
of a single ubiquitin moiety appears sufficient to specify
 
a
 
-factor receptor endocytosis (Terrell et al., 1998).
Both of the yeast pheromone receptors, the 
 
a
 
- and 
 
a
 
-fac-
tor receptors, have been well studied as paradigms for en-
docytosis. These two G protein–coupled receptors medi-
ate the hormonal communication that precedes the sexual
conjugation of the two yeast haploid mating types, the 
 
a
 
cell with the 
 
a
 
 cell. Though sharing no primary sequence
homology, both receptors couple to the same downstream
signaling pathway (Bender and Sprague, 1986). Our analy-
ses have focused mainly on the 
 
a
 
-factor receptor encoded
by the gene 
 
STE3
 
. Ste3p has the canonical G protein–cou-
pled receptor structure with seven transmembrane do-
mains followed at the COOH terminus by, in the case of
Ste3p, a relatively large 185-residue hydrophilic, cytoplas-
mically exposed, COOH-terminal tail domain (CTD).
 
1
 
The CTD is a regulatory domain and can be largely de-
leted without impairing the gross functioning of the recep-
tor, i.e., ligand binding and G protein coupling (Boone
et al., 1993). Though functional, receptors truncated for
this CTD manifest an unregulated response to the 
 
a
 
-factor
ligand that is both exaggerated and prolonged. In addition,
these mutant receptors are defective for the two uptake
modes that have been demonstrated for this receptor—a
constitutive or ligand-independent uptake mode, as well as
a ligand-dependent endocytosis (Davis et al., 1993; Tan et al.,
1996). Both modes involve ubiquitination (Roth and
Davis, 1996) and both deliver surface receptor to the vacu-
ole for degradation by the resident proteases (the vacuole
is the yeast equivalent organelle to the mammalian lyso-
some). Though both receptors are subject to the two up-
take modes, for the 
 
a
 
-factor receptor, constitutive endocy-
tosis is by far the more prominent, transporting unliganded
receptor from surface to vacuole for degradation with a 
 
t
 
1/2
 
of 15 min. Furthermore, at least for Ste3p, the two uptake
modes are mechanistically distinct. The two are controlled
by distinct signals mapping to distinct portions of the re-
ceptor CTD (Davis et al., 1993; Tan et al., 1996). Second,
the two are distinguished by the participating cellular
functions required for each: mutants in the ankyrin-repeat
protein Akr1p block constitutive endocytosis of the 
 
a
 
-fac-
tor receptor, yet have no effect on ligand-dependent up-
take (Givans and Sprague, 1997). In spite of these dif-
ferences, much of the mechanism may also be shared.
Receptor ubiquitination and vacuole-directed transport
are common to both and both are blocked by mutants in
the actin-associated function 
 
SLA2/END4
 
 (Roth and Davis,
1996), suggesting a requirement of the actin cytoskeleton
for both uptake modes.
 
1. 
 
Abbreviations used in this paper
 
: CTD, cytoplasmically disposed,
COOH-terminal domain; ORF, open reading frame. 
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In the present work we characterize the sequences
within the 
 
a
 
-factor receptor CTD required for its rapid
ligand-independent endocytosis, i.e., the constitutive en-
docytosis signal. Although an expanding collection of
plasma membrane proteins have now been shown to un-
dergo endocytosis in yeast, the signals that direct uptake
have been studied in just a few cases. For the two phero-
mone receptors, sequences required for ligand-dependent
endocytosis have been characterized. The 
 
a
 
-factor recep-
tor CTD sequence DAKSS has been shown to be required
for ligand-dependent uptake of a mutant receptor deleted
for the COOH-terminal two-thirds of its 128-residue-long
CTD (Rohrer et al., 1993). The central lysine in this se-
quence appears to serve as the acceptor site for ubiquitin
attachment (Hicke and Riezman, 1996). For the 
 
a
 
-factor
receptor, the sequence NPFXD is required for ligand-
dependent endocytosis (Tan et al., 1996).
The work that follows characterizes the sequences
within the 
 
a
 
-factor receptor, which direct its rapid, consti-
tutive endocytosis. We find that a 36-residue-long se-
quence directs both uptake as well as the associated ubiq-
uitination of the receptor. No obvious resemblance to
either the mammalian L- or Y-based endocytosis signals
or to the two signals characterized for the ligand-depen-
dent uptake of the two yeast pheromone receptors is ap-
parent. Instead, rich in both acidic and hydroxylated
amino acids, the Ste3p signal bears a resemblance to the
PEST sequences that direct ubiquitination and proteoso-
mal turnover of short-lived cytoplasmic and nuclear pro-
teins. Recent reports on two other yeast plasma mem-
brane proteins, the 
 
a
 
-factor export protein Ste6p and the
uracil permease Fur4p, identify similar PEST-like se-
quences as participating in their constitutive endocytosis
(Kolling and Losko, 1997; Marchal et al., 1998). Together
these three sequences likely represent a new class of en-
docytosis signal—signals where the primary function may
be to direct the addition of an initiating ubiquitin.
 
Materials and Methods
 
Plasmids
 
Three 
 
URA3
 
/2
 
m
 
 plasmids were constructed for 
 
CUP1
 
-driven overexpres-
sion of wild-type or myc-tagged ubiquitin (Ellison and Hochstrasser,
1991). pND186 (
 
CUP1
 
-ubiquitin), pND747 (
 
CUP1-
 
myc-ubiquitin), and
pND187 (
 
CUP1
 
 promoter only) were constructed through the replace-
ment of the ClaI–BamHI interval of YEp24 with the 
 
CUP1
 
-ubiquitin–
containing ClaI–BamHI fragment from the corresponding 
 
URA3/CEN/
ARS
 
 plasmids pND164, pND165, and pND167, respectively (Roth and
Davis, 1996).
The other plasmids constructed and used in this work divide into series
of equivalent constructs carrying either wild-type 
 
STE3
 
 or 
 
STE3
 
 mutant
versions. The strategy used in the construction of each series is reported in
the following three sections.
 
Construction of In-Frame Deletions
 
For constructing in-frame deletions within the Ste3p CTD, the general
strategy involved introduction of XhoI restriction sites by oligonucleotide-
directed mutagenesis at various positions within the 
 
STE3
 
 CTD-encoding
sequences. Restriction and then ligation of upstream to downstream sites
deletes the interval in between. Each XhoI site mutation replaced two ad-
jacent 
 
STE3
 
 codons with the sequence CTCGAG. Each replacement en-
coded the dipeptide leucine-glutamate and ligation of any two sites results
in in-frame translation across the deletion.
 
Eight XhoI site mutations were constructed, at each of the following
dipeptide codons: Leu
 
398
 
Lys
 
399
 
, Phe
 
413
 
Asp
 
414
 
, Ser
 
423
 
Lys
 
424
 
, Leu
 
433
 
His
 
434
 
,
Phe
 
441
 
Glu
 
442
 
, Leu
 
446
 
Cys
 
447
 
, Pro
 
450
 
Ala
 
451
 
, and Ser
 
458
 
Ser
 
459
 
. In addition, a
SalI site compatible with the XhoI sites was introduced at the Leu
 
320
 
Leu
 
321
 
dicodon changing it to Val
 
320
 
Asp
 
321
 
.
Oligonucleotide-directed mutagenesis was by the method of Kunkel et al.
(1987). The ssDNA template was derived from pSL1839, a 5.5-kb
BamHI–SalI fragment from the original 
 
STE3
 
 genomic library isolate
(Hagen et al., 1986) carried on pRS306 (Sikorski and Hieter, 1989). Mu-
tant plasmids for each restriction site were subjected to DNA sequencing
in the vicinity of the site to confirm the fidelity of the mutagenesis.
Two additional SalI restriction sites, compatible with the XhoI site
reading frames, were also used: the natural SalI site at 
 
STE3
 
 codons 364
and 365, as well as a SalI site introduced via linker ligation to the PstI site
located at 
 
STE3
 
 codons 466–468 (see pSL1922 in Davis et al., 1993). This
linker-derived SalI site was used in combination with the different XhoI
site mutants to construct the series of “COOH-terminally”-truncated
 
STE3
 
 mutants. In fact, these truly are in-frame deletions, as they all retain
the natural COOH-terminal STE3 dipeptide Gly
 
469
 
Pro
 
470
 
.
Assessment of receptor ubiquitination levels required that each of the
receptor mutants be overexpressed from the 
 
GAL1 
 
promoter. The plas-
mid pSL552 (Bender and Sprague, 1986) has a 
 
GAL1
 
-controlled wild-type
 
STE3
 
 gene carried on the yeast 
 
URA3/CEN/ARS
 
 plasmid YCp50 (Rose
et al., 1987). In-frame 
 
STE3
 
 deletions constructed above in the pSL1839
plasmid context, were introduced into pSL552 via replacement of 380-bp
SalI–SacI restriction fragment covering the COOH-terminal coding por-
tion of 
 
STE3
 
, with the equivalent fragment containing the desired dele-
tion mutation.
 
Construction of Triple Alanine Substitution Mutations
 
The 12 triple alanine mutations created within the 414–449 interval of
 
STE3
 
 (see Fig. 8) also were constructed via oligonucleotide-directed mu-
tagenesis (Kunkel et al., 1987). For each, three adjacent 
 
STE3
 
 codons are
replaced by the sequence GCTGCAGCC, encoding three consecutive ala-
nines. This substitution also introduces a PstI site, allowing identification
of the mutant clone by restriction analysis. The ssDNA template for mu-
tagenesis was from pND210, the 
 
D
 
450–468
 
 mutant version of pSL1839. Fi-
delity of mutagenesis was confirmed for each via DNA sequencing in the
vicinity of mutation site.
Two of the triple alanine mutations were also constructed within the
context of wild-type (i.e., full-length) 
 
STE3
 
. Reconstruction of 
 
STE3
 
 with
either the 417–419 or 426–428 triple alanine mutations (see Fig. 9) used
the HindIII site at codons 433, 434, allowing the wild-type COOH-termi-
nal 
 
STE3
 
 sequences to be restored to the 
 
STE3
 
D
 
450–468
 
 versions of these
mutations.
 
Construction of PMA1-STE3 Fusions
 
The plasmid pXZ28 (Harris et al., 1994) has a 
 
GAL1
 
-driven HA epitope–
tagged 
 
PMA1
 
 gene carried on a yeast 
 
URA3/CEN/ARS
 
 plasmid. The sin-
gle HA epitope tag inserted near the NH
 
2
 
-terminal coding sequences, fol-
lowing the second codon of 
 
PMA1
 
 does not affect 
 
PMA1
 
 function. The
750-bp EcoRI–XhoI pXZ28 
 
GAL1
 
 promoter fragment plus the 3.6-kb
XhoI–PstI 
 
HA-PMA1
 
–containing pXZ28 fragment were inserted into the
polylinker of the yeast 
 
LEU2/CEN/ARS
 
 vector pRS315 (Sikorski and Hi-
eter, 1989) between EcoRI and SacI to give pND533. This required modi-
fication of the PstI end of the 3.6-kb fragment by addition of a SacI linker.
The unique XhoI site of pND533, at the fusion boundary between 
 
GAL1
 
and 
 
PMA1
 
 sequences was destroyed via end-filling and re-ligation to give
pND542. To create pND563, the immediate progenitor of 
 
PMA1-STE3
 
fusion protein plasmids, a new XhoI site was introduced into 
 
PMA1
 
 by
oligonucleotide-directed mutagenesis at COOH-terminal position two
residues from the end of the coding sequences (the XhoI site substitutes
for the codons Lys
 
916
 
Glu
 
917
 
). The 
 
PMA1
 
 XhoI site is designed to accom-
modate in-frame fusions with the 
 
STE3
 
 XhoI sites. For most of these fu-
sions the XhoI site at 
 
STE3
 
 codons 398, 399 was used (see above) with the
contributed 
 
STE3
 
 sequences extending from codon 400 to different
COOH-terminal endpoints. For instance, to construct the 
 
PMA1
 
-
 
STE3(400–440)
 
 fusion protein, the 398, 399 XhoI site was introduced via
oligonucleotide-directed mutagenesis into the 
 
STE3
 
D
 
441–468
 
 deletion
mutant context. From this plasmid, a 250-bp XhoI–SacI fragment could be
excised (the SacI site is located 3
 
9
 
 of the 
 
STE3
 
 open reading frame [ORF])
and used to replace the XhoI–SacI fragment from the GAL1-HA-PMA1
plasmid pND563. 
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Strains
 
Genotype and source for some of the yeast strains used in this work are
reported in Table I. The two new strains listed, NDY343 and NDY344,
isogenic 
 
ste3
 
D
 
::LEU2
 
 versions of the strains NDY334 and NDY335 (Roth
and Davis, 1996), were constructed via the two-step gene replacement
strategy (Boeke et al., 1987) as described previously (Roth and Davis,
1996), wherein a 
 
ste3
 
D
 
::LEU2
 
 allele was used to replace 
 
STE3
 
. The 
 
ste3
 
D
 
::
LEU2
 
 allele, carried on the integrating plasmid pSL2165, a pSL1839 de-
rivative (see “Plasmids”), in which the entire 
 
STE3
 
 ORF is replaced by
the 2.85-kb BglII 
 
LEU2
 
 fragment. The 
 
ste3
 
 deletion extends from a point
417 bp upstream of the 
 
STE3
 
 ORF to a point 111 bp downstream.
pSL2165 was uniquely restricted at a SfiI site located upstream of 
 
STE3
 
 to
direct chromosome insertion.
In addition to the strains reported in Table I, numerous other strains
were constructed and used in this work. The turnover of each Ste3p mutant
was measured in strains in which the mutant 
 
STE3
 
 allele replaces the 
 
ste3
 
D
 
::
LEU2
 
 allele of NDY343. This strain construction used the two-step gene re-
placement strategy (Boeke et al., 1987) as previously described (Roth and
Davis, 1996). For each, the transplacing allele, derivatives of the integrating
plasmid pSL1839 with the mutant 
 
STE3
 
 in place of wild-type 
 
STE3
 
, were
restricted with HpaI to direct chromosomal insertion. This eliminated one
potential source of experimental variability—differences in receptor expres-
sion levels resulting from clonal fluctuations in plasmid copy number.
 
Antibodies
 
Rabbit antisera was raised against the STE3 CTD, as part of one of two
bacterial fusion proteins, TrpE-STE3 (Clark et al., 1988) or MalE-STE3.
All Ste3p-specific antisera were affinity purified to the MalE-STE3 anti-
gen coupled to CNBr-activated Sepharose 4B (Sigma Chemical Co., St.
Louis, MO). The HA.11 mAb (Berkeley Antibody Co., Berkeley, CA)
was used for detection of HA epitope–tagged PMA1-STE3 fusions. The
myc mAb (Oncogene Research, Uniondale, NY) was used for detection
of the myc 9E10 epitope–tagged ubiquitin (Ellison and Hochstrasser,
1991). Pgk1p-specific antiserum was generously provided by T. Stevens
(University of Oregon, Eugene, OR).
Cell Labeling, Extract Preparation, and
Immune Precipitation
Pulse-chase analysis (Roth and Davis, 1996) entailed in vivo labeling of
yeast cultures via a 10-min pulse of [35S]methionine, which was followed
by addition of the non-radioactive chase: methionine added to a concen-
tration of 750 mg/ml, cysteine to 150 mg/ml, and yeast extract to 0.2%. At
various times after chase addition, culture aliquots were removed and ex-
tracts were prepared by the glass bead method described previously (Roth
and Davis, 1996). Wild-type or mutant receptors were then isolated via
two iterative rounds of immunoprecipitation (Roth and Davis, 1996).
Each round used different affinity-purified anti-Ste3p antibodies derived
from the polyclonal antisera of different rabbits. Immunoprecipitated
samples were subjected to SDS-PAGE, and then both to autoradiography
and to Storm PhosphorImaging (Molecular Dynamics, Inc., Sunnyvale,
CA) for the quantitative analysis.
For immunoprecipitation of the HA-tagged PMA1-STE3 fusion pro-
teins, 20 ml of extract corresponding to 50 3 106 cells, prepared as de-
scribed (Davis et al., 1993), was subjected to a single round of immunopre-
cipitation (Roth and Davis, 1996) using 30 ml of a slurry of the HA.11
mAb conjugated to agarose beads (Berkeley Antibody Co.). Incubation
with the mAb in this case was for 16 h at 48C.
Susceptibility to External Proteases
To assess the susceptibility of newly synthesized receptor to digestion by
extracellular proteases, cells were first subjected to in vivo labeling via the
pulse-chase protocol described above. At various times after chase addi-
tion, culture aliquots were removed and intact cells were treated with Pro-
nase (Calbiochem-Novabiochem Corp., La Jolla, CA) and protein ex-
tracts were prepared (Davis et al., 1993). Immunoprecipitation and
further analysis was as described above.
Protein Extract Preparation, Western Analysis, and 
Phosphatase Treatment
For Western analysis, the relevant STE3 mutant or PMA1-STE3 fusion
protein was expressed from the GAL1 promoter. For these experiments,
overnight log-phase cultures in rich YP medium containing 2% raffinose
were inoculated from minimal plates on which plasmid retention was se-
lected. Induction of the GAL1 promoter involved the addition of galac-
tose to 2%. The duration of the galactose induction was as indicated for
each figure and was terminated when synthesis repression was desired
with the addition of glucose to 3%. Protein extract preparation, SDS-
PAGE, and Western analysis were as described previously (Roth and
Davis, 1993).
Treatment of protein extracts with potato acid phosphatase (Boeh-
ringer Mannheim Corp., Indianapolis, IN) at a final concentration of 0.06
U/ml was as described previously (Roth and Davis, 1996).
Quantitation of the Proportion of Receptor Protein with 
Attached Ubiquitin
Quantitating the proportion of receptor proteins with attached ubiquitin
was by Western analysis of phosphatase-treated protein extracts for the
various STE3 mutants. Quantitative AMBIS densitometry of films (AM-
BIS Systems, Inc., San Diego, CA) resulting from ECL development of
the Western blot (Amersham Corp., Arlington Heights, IL) was used to
estimate the relative amount of the receptor protein present in the two
ubiquitin-modified electrophoretic positions (the presumptive mono- and
di-ubiquitinated forms; Roth and Davis, 1996), and at the unmodified po-
sition. Many aspects of this analysis rely on techniques wherein the mea-
sured output is produced non-linearly. To circumvent this potential source
of error, we have compared signals only of similar intensity levels. This
was achieved by applying the Western analysis to a dilution series for each
sample. For instance, with phosphatase-treated extracts derived from
wild-type Ste3p, the intensity level of the signal associated with the mono-
ubiquitinated band was found to be intermediate between the level of the
unmodified receptor band present from the 1:5 and 1:25 dilutions of the
same extract. Quantitative densitometry of the band signals from the same
compared samples led to the determination that 10% of the wild-type re-
ceptor was present in the mono-ubiquitinated species band. As 10% was
also present in the di-ubiquitinated band, the summed estimate of 20%
was reported in Fig. 3 as proportion of receptor ubiquitinated.
Results
Identification of a Receptor Subdomain That Directs 
Rapid Constitutive Endocytosis
Our previous work showed that the rapid constitutive en-
docytosis of Ste3p requires sequence elements within the
COOH-terminal 72–amino acid residues of the receptor
(Davis et al., 1993). To better delineate this requirement
we have constructed a series of in-frame deletion mutants
within the receptor’s dispensable CTD. First we have first
investigated if CTD sequences in addition to the 72-resi-
due COOH-terminal segment are required for rapid con-
stitutive endocytosis. The 187-residue-long Ste3p CTD ex-
tends from Asp284 (the first charged residue after the
Table I. Yeast Strains
Strain Genotype Reference or source*
SY1574 MATa STE3 ura3 leu2 ade2-
1oc ade1 his6 trp1am
Davis et al., 1993; A
SY2601 MATa STE3 pep4D Roth and Davis, 1996; A
SY2602 MATa ste3D::LEU2 pep4D Roth and Davis, 1996; A
RH268-1C MATa end4-1 ura3 leu2
his4 bar1-1
Raths et al., 1993; B
NDY334 MATa END4 Roth and Davis, 1996; B
NDY335 MATa end4-1 Roth and Davis, 1996; B
NDY343 MATa ste3D::LEU2 END4 This work; B
NDY344 MATa ste3D::LEU2 end4-1 This work; B
*Strains designated A are isogenic to SY1574. Strains designated B are isogenic to
RH268-1C.Roth et al. Ubiquitin-directed Endocytosis 953
seventh transmembrane segment) to a COOH-terminal
Pro470. Three large deletion mutants, deleting residues 320–
363 (STE3D320–363), residues 365–414 (STE3D365–414),
and the COOH-terminal residues 413–468 (STE3D413–468)
were used. As a first assessment of endocytosis, the rate of
degradative turnover of each of the different receptor mu-
tants was determined (Fig. 1 A). While wild-type Ste3p
turns over rapidly with a t1/2 estimated to be z15 min, the
D413–468 mutant receptor is completely stable, indicating
that the COOH-terminal 58 residues are required for
this  ligand-independent receptor turnover. Like wild-type,
both the D365–414 and D320–363 receptors show rapid
turnover consistent with endocytosis that is largely unim-
paired. Thus, of the STE3 CTD sequences, the COOH-
terminal 58 residues play the primary role in specifying
rapid turnover. We have therefore concentrated our anal-
yses on this interval.
The turnover defect of Ste3D365–468p, a mutant missing
its COOH-terminal 105 residues, is a consequence of
blocked endocytic transport from surface to vacuole
(Davis et al., 1993). With endocytosis blocked the receptor
accumulates at the cell surface. If the turnover defect of
the D413–468 mutant receptor also results from impaired
endocytosis, then this receptor should also accumulate at
the cell surface. To assess surface localization of the D413–
468 receptor, we have used protease susceptibility as a
probe, testing the accessibility of the receptor within
whole cells to digestion by added, external protease. This
assay distinguishes surface-localized receptor (susceptible
to external proteases), from receptor that localizes to com-
partments inside the cell (resistant to external proteases)
(Davis et al., 1993). As for Fig. 1 A, cells were subjected to
pulse-chase analysis. At various times after the initiation
of the non-radioactive chase, aliquots of the labeled, intact
cells were subjected to protease treatment (Fig. 1 B). Di-
gestion of surface-localized receptor is evident both in
terms of loss of receptor protein and by the production of
a protease digestion product corresponding to the pro-
tected, intracellular CTD plus final transmembrane do-
main (Davis et al., 1993; the antibody used for the immu-
noprecipitation is STE3 CTD specific). Wild-type Ste3p in
such a regimen is only transiently susceptible to the added
proteases, reflective of its short surface residency time
(Davis et al., 1993). Here, we find that the D413–468 mu-
tant receptor remains susceptible to the proteases even 90
min after synthesis (Fig. 1 B). Quantitation via Phosphor-
Imaging indicates that 75% of D413–468 receptor protein
is susceptible to protease 45 min after synthesis and 60%
remains susceptible at the 90-min time point. Cell integrity
is maintained throughout the digestion protocol as evi-
denced by the complete protection from digestion of a cy-
toplasmic marker protein, phospho-glycerol kinase (Pgk1p;
Fig. 1 B, bottom panel). We conclude from its prolonged
surface residency time that turnover defect found for
Ste3D413–468p does indeed reflect impaired endocytosis.
Deletional Analysis of the Sequences Required for 
Rapid Endocytosis and Turnover
To identify the sequence element(s) that direct the consti-
tutive endocytosis of Ste3p we have constructed a finer se-
ries of deletions within the 413–468 interval. First we
tested the effects of three deletions extending progres-
sively in from the receptor COOH terminus. The in vivo
rate of turnover was assessed for wild-type Ste3p and for
each mutant receptor via a pulse-chase regimen similar to
that described for Fig. 1 A. Immunoprecipitated receptors
were subjected to SDS-PAGE (Fig. 2 A) and then to Phos-
phorImaging analysis to quantitate their rate of loss to
degradation (Fig. 2 B). As seen previously (Fig. 1 A), turn-
over is rapid for wild-type Ste3p and wholly blocked for
Ste3D413–468p. The two intermediate deletion mutants,
D450–468 and D441–450 show intermediate rates of turn-
over. Quantitation of the receptor-associated radioactivity
at each time-point is shown in Fig. 2 B. Most of the data
points for each receptor conform to a linear plot, allowing
the calculation of turnover half-life for each mutant (Fig. 2
B). For wild-type Ste3p, a t1/2 of 16 min is calculated. For
Ste3D450–468p, turnover remains rapid, though somewhat
less so than wild-type: a t1/2 of 21 min is calculated. With
the progressive extension of these deletions, a progressive
impairment is evident. A t1/2 of 65 min is calculated for the
D441–468 receptor and the turnover block appears to be
complete for the D413–468 receptor.
For two of the receptors, namely wild-type and D450–
468, the 90-min time-points fail to conform to the line de-
fined by the other time-points (Fig. 2 B). This is seen con-
sistently and indicates that a minority of these receptors,
Figure 1. Analysis of the CTD sequences that con-
tribute to the rapid, constitutive endocytosis of
Ste3p. Yeast strains were subjected to [35S]methio-
nine pulse-chase analysis as described in the Materi-
als and Methods. (A) Contribution of CTD se-
quences to Ste3p constitutive turnover. Cells from
four isogenic strains were tested: NDY334, a wild-
type MATa strain, as well as three strains differing
only in their STE3 allele, these being either
STE3D413-468,  STE3D365-414, or STE3D320-363.
Receptor immunoprecipitated from labeled extracts prepared at the indicated chase times was subjected to SDS-PAGE, and then visual-
ized by autoradiography. (B) Surface-localization assessment for the turnover defective deletion mutant receptor Ste3D413-468p. The
STE3D413-468 strain of part A was subjected to pulse-chase analysis as above. At the two indicated chase times, 45 min and 90 min after
addition of the excess non-radioactive methionine and cysteine, culture aliquots were removed and whole, energy-poisoned cells were
treated with proteases (1), or mock-treated (2), as described in the Materials and Methods. Protein extracts prepared from each sample
were subjected to immunoprecipitation with either Ste3p-specific (top panel) or Pgk1p-specific (bottom panel) antibodies, followed by
SDS-PAGE and autoradiography. The arrow at right indicates the position of the protected, CTD digestion product for Ste3D413-468p.The Journal of Cell Biology, Volume 142, 1998 954
3% for wild-type and 13% for Ste3D450–468p, do not par-
ticipate in the normal endocytic turnover mechanism. Hy-
pothetically, these could be receptors in the process of un-
dergoing recycling or receptors that are trapped to a locale
that prohibits their endocytosis.
Fig. 3 summarizes the results from a total of eight
COOH-terminal deletion mutants. Again, it is apparent
that endocytic function is lost gradually with progressive
removal of sequences from the COOH-terminal end. A
small, but significant slowing of the turnover rate is appar-
ent with removal of the COOH-terminal 12 amino acids
(Fig. 3; t1/2 of 25 min for D458–468 vs. 15 min for wild-
type). A second transition is broached with the D447–468
deletion; the t1/2 for turnover slows from 25 to 40 min. Fur-
ther impairment is seen when the deletion is extended to
residue 441, with the t1/2 for D441–468 being 70 min. Fi-
nally, with the deletion extended to residue 423, endocyto-
sis appears to be wholly blocked. This gradual loss of func-
tion for deletions extending over the COOH-terminal 48
amino acids indicates the “signal” for constitutive endocy-
tosis may be large and complex, potentially composed of
redundant functional elements.
To delimit the upstream boundary of this endocytosis
signal, small internal deletions were introduced into the
D450–468 mutant receptor. The D450–468 deletion re-
moves the COOH-terminal 20 amino acid residues and
was used as the context for these other small deletions to
eliminate the potential contribution of redundant ele-
ments within the 450–470 interval. The experiment of Fig.
1 indicated that a large portion of the receptor CTD (the
320–414 interval) is not required for rapid endocytic turn-
over. Again here within the D450–468 context, introduc-
tion of a second deletion of residues 398–414 caused no
additional defect; the t1/2 for turnover of the double dele-
tion mutant D398–414, 450–468 was unchanged from that
of the parental D450–468 construct (Fig. 3). However, in-
troduction of either the D413–424 or the D423–434 dele-
Figure 2. Turnover rate of different COOH-terminally truncated
a-factor receptors. The wild-type MATa strain NDY334 and
three isogenic strains with different transplaced STE3 alleles:
STE3D450-468,  STE3D441-468, or STE3D413-468 were subjected
to pulse-chase analysis and otherwise treated as described for Fig.
1 A. (A) Effect of COOH-terminal deletions on receptor turn-
over. Autoradiography of the SDS-PAGE of the immunoprecipi-
tated receptor mutants. (B) Determination of the turnover t1/2 for
the receptor mutants. Phosphorimager analysis was applied to
the polyacrylamide gel of A (Materials and Methods). For each
strain, the radioactivity associated with receptor bands at the ini-
tial 1-min chase time-point was normalized to 100%. A semi-log
plot of the radioactivity remaining associated with the receptor
bands at each of the subsequent chase time-points is shown. For
each strain, a turnover t1/2 was calculated (indicated for each as
t1/2) from the slope of the line drawn through the linear portion of
each data set.
Figure 3. Summary of turnover rates and the proportion of re-
ceptor proteins that are ubiquitinated for a collection of STE3
deletion mutants constructed within the COOH-terminal 73
amino acid residues of Ste3p. Shown in the upper left is the hy-
pothesized transmembrane structure for Ste3p. The region corre-
sponding to the COOH-terminal 57 residues of the Ste3p CTD is
highlighted, the 414–451 interval indicated with a striped box and
the 451–470 interval by a stippled box. Shown below are se-
quences deleted (dotted line) for each of the different in-frame
STE3 deletion mutants tested. To the right, the exact amino acids
residues removed for each mutant are indicated. The two col-
umns at the right summarize the results of the two different ex-
periments that were performed for each receptor, these being: (1)
measurement of the turnover t1/2, and (2) measurement of the
proportion of the receptors found to be ubiquitinated. Measure-
ment of turnover rate used a collection of strains isogenic to
NDY334, except for the indicated STE3 mutant alleles. As de-
scribed in Fig. 2, each strain was subjected to pulse-chase label-
ing, immunoprecipitation, SDS-PAGE, phosphorimaging, and
turnover t1/2 calculation. In terms of experimental variability,
half-lives calculated from different experiments were within 20%
of the reported value for each mutant. Different conditions were
required to assess receptor ubiquitination levels. Cells of the
MATa ste3D pep4D strain SY2602 transformed by either pSL552
(GAL1-STE3) or by the identical plasmid with the indicated
STE3 deletion allele in place of the wild-type STE3 were grown
and processed as described for Fig. 4 A. Quantitation of the pro-
portion of receptor antigen localizing to the putative mono- and
di-ubiquitinated receptor species was as described in the Materi-
als and Methods. The values reported in the far right-hand col-
umn represent the combined sum of the receptor antigen present
in the mono- and di-ubiquitinated forms. For the D398-468 recep-
tor mutant the proportion of receptor ubiquitinated was not de-
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tions into the D450–468 receptor wholly blocked turnover.
This indicates that sequences required for rapid endocyto-
sis extend to the NH2-terminal side of residue 423, poten-
tially as far as residue 413. Thus, the 36-residue-long 414–
449 sequence interval appears to be the most critical for
directing rapid endocytosis. Consistent with this, deletion
of just these amino acids (STE3D413–451) abolishes turn-
over (Fig. 3). However, the COOH-terminal 20 residues
also may contribute to turnover: both the D450–468 and
D458–468 deletions have small, but significant effects on
the turnover rate (Figs. 2 and 3). Support for the participa-
tion of the COOH-terminal 20 residues in endocytosis is
offered below (see Fig. 9) with experiments indicating a
functional redundancy between sequence elements in the
414–449 interval and those in the 450–470 interval.
Sequences That Direct Receptor Endocytosis Also 
Direct Receptor Ubiquitination
We next tested if the STE3 mutants defective for constitu-
tive endocytosis are also defective for the associated con-
stitutive ubiquitination. Receptor ubiquitination levels of
the various STE3 mutants were assessed via Western anal-
ysis: ubiquitinated receptor species manifest an 8-kD shift
with each added ubiquitin moiety. Detection of the ubiq-
uitinated forms is improved with the use of several key ex-
perimental conditions, including receptor overproduction
(z10-fold) from the GAL1 promoter. This enhances de-
tection of the ubiquitinated forms, yet neither alters recep-
tor turnover rate nor the proportion of the receptor sub-
ject to ubiquitination (data not shown). Secondly, to avoid
loss of the ubiquitinated forms to vacuolar degradation,
pep4D mutants deficient in vacuolar protease activity were
used. Finally, treatment of protein extracts with phos-
phatase before electrophoresis eliminates the substantial
heterogeneity in gel mobility because of the heterogenous
phosphorylation of Ste3p (Fig. 7; also Roth and Davis,
1996).
In Fig. 4 A, the ubiquitination of three receptor mutants
is compared with wild-type. For wild-type, the majority
species (z80%) has no attached ubiquitin (Roth and
Davis, 1996). The remaining 20% distributes almost
equally between two, more slowly-migrating, ubiquiti-
nated forms (indicated in Fig. 4 A, arrows at left), the
mono- and di-ubiquitinated receptor species (Roth and
Davis, 1996). Mutants that block endocytosis, namely
D413–468 and D413–451 (Fig. 3), also blocked receptor
ubiquitination (Fig. 4 A). Furthermore, the D450–468 mu-
tant receptor that showed diminished turnover (Fig. 2)
also shows diminished ubiquitination (Fig. 4 A). Quantita-
tion of these results along with similar analyses applied to
the other mutant receptors is reported in Fig. 3. Compari-
son of the turnover half-life with ubiquitination levels
shows a consistent correlation between the two—further
compelling evidence for a functional connection linking
ubiquitination and endocytosis.
Previously, we have shown that in end4-1 cells, constitu-
tive Ste3p endocytosis is blocked and the receptor is con-
sequently trapped at the cell surface in a ubiquitinated
state (Roth and Davis, 1996). Here, we again make use of
the end4 mutant strain background to eliminate endocyto-
sis as a possible contributing cause to the differences seen
in ubiquitination levels for the different receptor mutants.
If, for instance, ubiquitin addition occurred at some post-
surface, endosomal step, then mutations like D413–468,
which block uptake, might block ubiquitination by pre-
venting access of the receptor to downstream steps. In
such an experiment (Fig. 4 B), essentially the same result
is seen as was apparent in the END41 background (Fig. 4
A). While both the wild-type and D450–468 receptors are
ubiquitinated, the D413–468 receptor is not, and the D441–
468 receptor shows greatly reduced levels of ubiquitina-
tion. Ste3p ubiquitination, therefore, likely occurs while
receptor is surface localized, serving potentially as the ini-
tiating trigger for uptake.
Sufficiency of the Signal for Ubiquitination
and Endocytosis
We have identified a domain mapping to the COOH-ter-
minal portion of the receptor’s CTD that directs both the
ubiquitination and the rapid constitutive endocytosis of
the receptor. In this section we test the sufficiency of this
sequence to direct the ubiquitination and endocytosis of a
normally long-lived constituent of the plasma membrane,
the plasma membrane ATPase Pma1p. Like Ste3p, Pma1p
is a polytopic plasma membrane protein with a cytoplas-
Figure 4. Assessment of receptor ubiquitination levels for STE3
deletion mutants. (A) Phosphatase-treated STE3 deletion mutant
receptors expressed from the GAL1 promoter in a pep4D cells. 2 h
of growth in galactose medium was used to induce receptor ex-
pression in MATa ste3D pep4D cells (strain SY2602) transformed
by a CEN/ARS plasmid with wild-type (wt) STE3 under the con-
trol of the GAL1 promoter (pSL552), or by the equivalent plas-
mid having one of three different STE3 mutant alleles, either
STE3D450-468, STE3D413-468, or STE3D413-451. Extracts were
prepared and subjected to phosphatase digestion, SDS-PAGE,
and finally anti-Ste3p immunoblot analysis. Positions of the puta-
tive mono- and di-ubiquitinated forms of wild-type Ste3p (lane 1)
are indicated by the arrows at left. The arrow at right indicates
the position of a band that cross-reacts with the Ste3p-specific an-
tibodies in these immunoblot analyses. (B) The effect of the
end4-1 mutation on the ubiquitination levels of the STE3 dele-
tion mutants. Cells of the MATa ste3D end4-1 strain (NDY344)
transformed by the GAL1-STE3 plasmid pSL552 (wt), or by the
equivalent plasmid with one of three STE3 mutant alleles, either
STE3D450-468, STE3D441-468, or STE3D413-468 were grown for
2 h in galactose medium, to induce receptor expression. Further
receptor synthesis was then repressed with 3% glucose and
growth was continued for an additional 2 h. Extracts were pre-
pared, treated with phosphatase, and otherwise analyzed as de-
scribed above for A. Though the end4 strain is temperature sensi-
tive, the Ste3p is wholly defective for endocytosis even at
permissive temperatures (Roth and Davis, 1996). Thus, in this
and other experiments using the end4-1 mutation all growth of
cells is at 308C.The Journal of Cell Biology, Volume 142, 1998 956
mically exposed, COOH-terminal tail. Unlike Ste3p,
Pma1p is quite stable with a t1/2 estimated at .11 h (Benito
et al., 1991). By site-directed mutagenesis, an XhoI site
was created at the penultimate PMA1 codon to provide a
locus for the in-frame fusion of the various STE3 se-
quences to be tested. Fusions are expressed from the
GAL1  promoter, and have embedded near the NH2-termi-
nal–encoding end of the PMA1 ORF, a single HA epitope
tag that does not impair PMA1 function (Harris et al.,
1994). Thus, turnover of the fusion proteins may be easily
assessed as follows: (a) PMA1-STE3 proteins are ex-
pressed via growth on galactose-containing medium, (b)
synthesis of the construct protein is then blocked with the
addition of glucose, and (c) the time-dependent loss is fol-
lowed via immunoblotting with anti-HA mAb. This same
experimental system was used previously to show that a
108-residue portion of Ste6p sufficed to direct endocytosis
of a PMA1-STE6 fusion protein (Kolling and Losko, 1997).
Five different PMA1-STE3 fusion proteins were con-
structed, each with a different segment of the STE3 CTD
fused at the COOH terminus of PMA1. The parental HA-
tagged Pma1p showed no evidence of turnover during the
2-h course of this experiment (Fig. 5). Attachment of the
347–398 STE3 sequence interval was without effect; this
PMA1-STE3 fusion protein shows a stability equivalent to
that of the starting PMA1 construct (Fig. 5). In contrast,
attachment of the 400–470 interval, encoding the COOH-
terminal 71 amino acids of Ste3p, does destabilize the re-
sulting PMA1-STE3 fusion protein (Fig. 5). This fusion
protein is degraded with a t1/2 of 40 min (Table II). Like-
wise, the fusion carrying the 400–449 STE3 sequence inter-
val also turns over (Fig. 5); a t1/2 of 50 min is calculated for
this protein (Table II). Turnover slows dramatically when
the critical 414–449 interval is violated as it is for PMA1-
STE3(400–440) (Fig. 5); a t1/2 of 90 min is calculated (Table
II). Finally, removal of the entire 414–449 interval, as
for PMA1-STE3(400–412), effectively abolishes turnover
(Fig. 5; Table II).
In addition to the five PMA1-STE3 constructs described
above, four additional constructs were made with the
STE3 contribution extending various distances into the
critical 414–449 interval. These constructs were subjected
to analyses identical to those in Fig. 5 and the resulting cal-
culated turnover t1/2 is reported for each (Table II). In gen-
eral, these results correlate quite well with the role of
these sequences in Ste3p turnover (Fig. 3). Sequences that
showed an intermediate rate of turnover in the Ste3p con-
text also show intermediate effects when tested in the
PMA1-STE3 context. In addition, we find that the mini-
mal endocytic signal, the 414–449 STE3 interval, suffices
to promote turnover of the resulting PMA1-STE3 fusion
(Table II).
Degradation of Ste3p depends on transport from the
cell surface to the vacuole (Davis et al., 1993; Roth and
Davis, 1996). Is the turnover of the PMA1-STE3 con-
structs instigated by a similar route of transport? To test
involvement of vacuolar proteases in PMA1-STE3 fusion
turnover, constructs with the STE3 400–449 peptide se-
quence interval were introduced into isogenic PEP41 and
pep4D strains and turnover assessed. While turnover pro-
ceeds in the PEP41 background, in the pep4D context,
turnover is completely blocked (Fig. 6, left panel). This is
also true for the longer PMA1-STE3(400–470) fusion pro-
tein (data not shown). Thus, like wild-type Ste3p, turnover
of these PMA1-STE3 fusions also depends on vacuolar
proteases and therefore also likely depends on transport
to the vacuole.
To test the dependence of turnover on endocytic trans-
port, an end4 mutant was used. The PMA1-STE3(400–
449) fusion was introduced into isogenic END41 and end4-1
cells. Turnover is blocked in the end4 background (Fig. 6,
right panel), indicating that as for Ste3p itself, turnover of
the PMA1-STE3(400–449) fusion depends on its endocy-
Figure 5. Stability of different PMA1-STE3 fusion proteins.
Turnover analysis performed on cells of the MATa strain SY1574
transformed either by a CEN/ARS plasmid carrying an HA
epitope-tagged version of Pma1p under the control of the GAL1
promoter (pND542) is shown in the top panel. The five panels
below show the same analysis applied to cells transformed by five
versions of the pND542 plasmid, having the two COOH-terminal
Pma1p codons replaced by the indicated Ste3p sequence interval.
For this analysis, galactose (2%) was added for 1 h, followed by
the addition of glucose to 3%, and at the indicated times thereaf-
ter, culture aliquots were removed and protein extracts prepared.
Extracts were subjected to SDS-PAGE, followed by immunoblot
analysis using anti-HA mAb.Roth et al. Ubiquitin-directed Endocytosis 957
tosis from cell surface to vacuole. Again, this is also true
for the PMA1-STE3(400–470) fusion as well (data not
shown).
Also apparent in the end4 background is the presence of
modified forms of the 400–449 PMA1-STE3 fusion that
migrate more slowly than the mature fusion protein band
(Fig. 6, species indicated by arrowhead). Although accen-
tuated by end4, a similar modification of the PMA1-
STE3(400–449) fusions was apparent both in the wild-type
strain backgrounds (Fig. 5) and in the pep4D background
(Fig. 6, left panel). Such modified species also were seen
for the longer PMA1-STE3(400–470) fusion, but were not
seen either for the other fusions or for the HA-tagged
Pma1p alone (Fig. 7 B).
To test if the modification is ubiquitination, we have
made use of a myc epitope–tagged ubiquitin (Ellison and
Hochstrasser, 1991). Multi-copy yeast plasmids expressing
either wild-type ubiquitin, the myc-tagged ubiquitin, or no
ubiquitin were introduced into end4 cells with one of three
PMA1-STE3 constructs, the 400–470 fusion, the 400–449
fusion, or the long-lived 400–412 fusion. The PMA1-STE3
fusion proteins were purified from extracts of these cells
via immunoprecipitation with the HA mAb. Immunoblot-
ting of the purified fusion proteins with the HA mAb, al-
lowed visualization of the fusion constructs and showed
that overexpression of either the wild-type or epitope-
tagged ubiquitin results in no obvious change in the
PMA1-STE3 fusion protein electrophoretic mobility (Fig.
7 A). Parallel immunoblots, probed instead with the myc
mAb, allowed assessment of the incorporation of the myc-
tagged ubiquitin into the fusion constructs (Fig. 7 A). The
stable 400-412 fusion, did not react with the anti-myc mono-
clonal (Fig. 7 A). In contrast, both the 400–449 and 400–
470 fusions showed a clear reaction. Reaction was specific
for cells coexpressing the myc epitope–tagged ubiquitin.
The 400–470 fusion showed a somewhat stronger reaction
than did the 400–449 fusion (Fig. 7 A), consistent with a
greater proportion of this fusion protein being ubiquitin
modified.
Using our panel of PMA1-STE3 fusions, we next tested
the STE3 sequence requirement for the ubiquitin modifi-
cation. Extracts prepared from end4 cells expressing each
of the different PMA1-STE3 fusions were subjected to
Western analysis with the HA mAb (Fig. 7 B). A promi-
nent accumulation of modified forms is apparent for the
two fusions retaining the critical 414–449 interval, i.e., the
400–449 and 400–470 fusions (Fig. 7 B). Smaller fusions vi-
olating the integrity of 414–449 STE3 interval do not show
this massive accumulation of modified species (Fig. 7 B).
(The minor species migrating slightly above the major fu-
sion protein band for each of these other fusions is not
likely to represent ubiquitinated protein: the 400–412 fu-
sion that manifests this minor species in Fig. 7 B, fails to
react with myc mAb in Fig. 7 A.) Thus, just as truncation
of the 414–449 interval impairs Ste3p ubiquitination, intru-
sion into this interval also abolishes ubiquitination of the
corresponding PMA1-STE3 fusion proteins. We conclude
that the 414–449 STE3 sequence interval is the minimal
signal that suffices to specify both ubiquitination and en-
docytosis.
Mutational Analysis of the Endocytosis Signal
The 36-residue-long 414–449 peptide sequence comprises
a ubiquitination/endocytosis signal for Ste3p. To gain in-
sight into the nature of this sequence, we have applied ala-
nine-scanning mutagenesis across this entire interval.
Again, to avoid the potential effects of redundant signal
elements within the 450–470 interval, mutations were
made within the STE3D450-468 context. 12 mutants in to-
tal spanning the 414–450 interval were constructed (Fig.
8). For each, three adjacent residues were substituted by
three alanines. Each mutant was subjected to pulse-chase
analysis identical to that previously applied to the various
STE3 deletion mutants (Figs. 1 and 2). The calculated t1/2
are reported in Fig. 8.
Results from the alanine scanning show a good concor-
dance with the deletion analysis (Fig. 3). While the dele-
tion analysis indicated a requirement of the entire 414–449
interval, the 414–433 interval was found to be particularly
crucial. For instance, though grossly impaired, the D441–
468 and D434–468 receptor mutants still showed a slow
Table II. Half-lives of PMA1-STE3 Fusion Proteins
STE3 sequences in PMA1-STE3 fusions t1/2 of PMA1-STE3 fusions*
none (HA-Pmalp) .2 h
400–470 40 min
400–449 50 min
400–446 70 min
400–440 90 min
400–433 90 min
400–422 .2 h
400–412 .2 h
415–449 50 min
347–398 .2 h
*The turnover half-lives reported are the rate of loss of HA antigen at the position of
full-length PMA1-STE3 fusion protein measured through AMBIS quantitative densi-
tometry of the original films from the experiment shown in Fig. 5 and from analogous
experiments.
Figure 6. Effects of pep4 and end4 mutations on the turnover of
the PMA1-STE3(400–449) fusion protein. For the experiment in
the left panel, the GAL1-HA-PMA1-STE3(400–449) plasmid de-
scribed for Fig. 5 was used to transform either the wild-type
MATa strain SY1574 (PEP41) or the isogenic pep4D version
SY2601. For the experiment shown in the right-hand panel, the
same plasmid was used to transform either the wild-type MATa
strain NDY334 (END41) or the isogenic end4-1 version
NDY335. For both experiments, after a 2-h exposure to galactose
(2%), glucose was added to 3%, and at the indicated times there-
after, culture aliquots were removed and protein extracts were
prepared. Extracts were subjected to SDS-PAGE, followed by
immunoblot analysis using anti-HA mAb. The arrowhead to the
right of the right-hand panel indicates the position of a modified
form of the PMA1-STE3(400–449) fusion protein that is accentu-
ated in extracts from the end4 cells.The Journal of Cell Biology, Volume 142, 1998 958
rate of turnover (t1/2 5 70 min; Fig. 3). Deletions that vio-
lated the more critical 414–433 interval (e.g., D423–468 or
D413–468) completely abolished turnover. Likewise for
the triple alanine mutations, mutations that totally dis-
abled endocytosis were concentrated within the crucial
414–433 interval; of the five mutants with t1/2 of .2 h, four
locate within the 414–433 interval (Fig. 8). Alanine muta-
tions in the 434–450 interval generally showed intermedi-
ate levels of impairment (Fig. 8). The one exception to this
is the replacement of the Ser-Ser-Asn 438–440 tripeptide,
which appeared to fully disable endocytosis. We are pres-
ently without an explanation of how this triple alanine re-
placement could have a more severe phenotype than the
deletion interval encompassing it.
The number of these triple alanine mutations having
pronounced effects on turnover is striking (Fig. 8). Resi-
dues important for endocytosis distribute throughout the
414–450 interval. No singular sequence motif is discern-
ible. Instead, the entire 36-residue-long sequence is re-
quired in its totality. The most prominent feature of this
interval, which we later discuss, is the high proportion of
acidic (glutamates and aspartates) and hydroxylated resi-
dues (serines and threonines).
Redundant Elements within the 450–470 STE3 Interval
The 414–449 sequence is the minimal ubiquitination/en-
docytosis signal. This, however, does not exclude the pos-
sible participation of other STE3 sequences. A small, but
reproducible effect on turnover was seen, for instance,
with removal of the COOH-terminal 20 amino acids: the
t1/2 for Ste3D450–468p is 25 min compared with 15 min for
wild-type (Fig. 2). Furthermore, like the 414–449 interval,
the 450–470 interval is also rich in both acidic and hydrox-
ylated amino acids. To test the contribution of these se-
quences to endocytosis, we have examined several muta-
tions that were known to disable turnover in the D450–468
receptor, within the context of the full-length receptor.
The triple alanine replacements were constructed and
tested originally within the context of the D450–468 de-
leted receptor. Two of these that had disabling effects in
the D450–468 receptor, were chosen and reconstructed in
the full-length receptor context. The effects on the rate of
receptor turnover were tested via pulse-chase analysis in
both contexts (Fig. 9). In the D450–468 context, both mu-
tations severely retard endocytic turnover. Where the
D450–468 receptor turns over with a t1/2 of 25 min, the
same receptor with the triple alanine substitution of the
Thr-Leu-Asp tripeptide at 426–428 turns over with a t1/2 of
90 min (Fig. 9). The effect of the alanine substitution of
Figure 7. The STE3 signal directs ubiquitina-
tion of PMA1-STE3 fusion proteins. (A) Im-
mune precipitation of PMA1-STE3 fusion pro-
teins from end4 cells overexpressing a myc
epitope–tagged ubiquitin. Two plasmids were
used to doubly transform cells of the MATa
end4-1 strain RH268-1C: (1) a LEU2/CEN/
ARS GAL1-HA-PMA1-STE3 plasmid derived
from pND542, with the STE3 contribution be-
ing either the 400–412 Ste3p interval, the 400–
449 interval, or the 400–470 interval, and with
(2) a URA3/2m plasmid for CUP1-driven over-
expression of wild-type or myc-tagged ubiq-
uitin, either pND186 (u, wild-type ubiquitin), pND747 (m, myc-ubiquitin), pND187 (2, no ubiquitin). As an immunoprecipitation con-
trol, one cell was transformed both with the myc-ubiquitin plasmid pND747 and with the vector plasmid pRS315 (Sikorski and Hieter,
1989) in place of a PMA1-STE3–expression plasmid (no fusion). Transformants were subjected to a culture protocol that included growth
at 308C in media containing 100 mM CuSO4 for 1 h (to induce ubiquitin expression), and then 2 h in the presence of 2% galactose (to in-
duce PMA1-STE3 fusion protein expression), and finally 1 h in the presence of 3% glucose (to repress PMA1-STE3 expression). Extracts
prepared from these cells were immunoprecipitated using the HA.11 mAb conjugated to Sepharose beads, and then subjected to SDS-
PAGE followed by Western analysis. Duplicate nitrocellulose transfer membranes were developed with either the HA.11 mAb (top
panel) or the myc mAb (bottom panel). (B) The STE3 sequence requirement for ubiquitination. Cells of the MATa end4-1 strain
NDY335 were transformed by various GAL1-HA-PMA1-STE3 plasmids derived from pND542. The plasmids differ in terms of the STE3
sequences fused at the COOH terminus. For each, the contributed STE3 sequence extends from Ste3p residue 400 to the residue indi-
cated above each lane. The six different transformants were subjected to a culture protocol at 308C, which included a 1 h exposure to 2%
galactose, followed by 1 h in 3% glucose. Protein extracts were prepared and analyzed as described for Fig. 5. The brackets to the right in-
dicate the position of the more slowly migrating modified forms of the PMA1-STE3(400–449) and PMA1-STE3(400–470) fusion proteins.
Figure 8. Effect of the triple alanine mutations on the turnover
rate of Ste3D450-468p. The amino acid sequence of the 45
COOH-terminal residues of Ste3D450-468p is shown. Numbers
above correspond to residue numbering of wild-type Ste3p and
the minimal signal domain residues 414–449 is highlighted with
bold face type. The D450–468 deletion is indicated with the leu-
cine-aspartate-arginine (LDR) tripeptide in place of the removed
19 STE3 residues. 12 mutants alleles were constructed each hav-
ing three consecutive residues (underlined) replaced by three ala-
nines. Strains isogenic with NDY334 except for the mutant triple
alanine STE3 allele replacement at the STE3 locus were sub-
jected to pulse-chase analysis identical to that of Fig. 2. The turn-
over t1/2 calculated for each is indicated below.Roth et al. Ubiquitin-directed Endocytosis 959
the 417–419 tripeptide Ile-Ser-Leu is even more severe,
showing a t1/2 of .2 h (Fig. 9). In the full-length receptor
context, while the two triple alanine mutations do cause
some slowing of turnover, the effects are far less severe.
While the wild-type receptor turns over with a t1/2 of 12
min in this experiment, for triple alanine substitutions at
417–419 and at 426–428, turnover is slowed only to a t1/2 of
21 and 17 min, respectively (Fig. 9). We conclude there-
fore that elements within the 450–470 sequence may com-
pensate the loss of key elements in the 414–449 interval.
We have seen previously that extension of a COOH-ter-
minal deletion from residue 450 to residue 441 severely
impairs endocytic turnover (Figs. 2, 3, and 9; compare
D450–468 with D441–468). This implies a critical role for
the 441–449 sequence. To test the importance of these se-
quences in an otherwise full-length receptor, we have con-
structed a receptor mutant in which only the 441–451 se-
quences are deleted. Like the two triple alanine mutants
tested above, the D441–451 deletion has only minor effects
in the full-length receptor context (Fig. 9). Again this sug-
gests a functional redundancy between elements in the
414–449 interval with elements in the COOH-terminal
450–470 interval. It may be that the entire 57-residue-long
segment from 414 to the COOH terminus normally func-
tions to specify Ste3p ubiquitination and endocytosis. The
414–449 interval, highlighted by our deletion analysis may
correspond simply to that minimal portion still capable of
promoting rapid endocytosis.
Discussion
We have characterized the sequences within the yeast
a-factor receptor that direct its rapid, ligand-independent
endocytosis. The essential sequence is striking, both in
terms of its large size, minimally defined as 36 residues
long, and its high density of both acidic amino acids and
hydroxylated amino acids, particularly serine. Not only
does this sequence specify uptake, but also ubiquitination.
Receptor mutants that lack this sequence are not ubiquiti-
nated and mutants partially deleted for this interval show
a reduced level of ubiquitination that correlates well with
their residual capacity for endocytosis. This sequence also
is a sufficient, self-contained, transportable unit. When
transplanted into the normally stable cell surface protein
Pma1p, the STE3 sequence directs both ubiquitination
and endocytosis: the result being delivery of the PMA1-
STE3 fusion protein to the vacuole for degradation.
Examination of the STE3 signal by visual inspection and
by alanine-scanning mutagenesis reveals no obvious simi-
larities to the short L- or Y-based peptidyl signals that
mediate clathrin-dependent uptake in mammalian cells
(Mellman, 1996; Schmid, 1997). Furthermore, no example
of the two sequences that have been previously associated
with the ligand-dependent uptake modes of the two yeast
pheromone receptors are apparent (Rohrer et al., 1993;
Tan et al., 1996). The large size of the STE3 ubiquitina-
tion/endocytosis signal could reflect a folding requirement
to a particular three-dimensional shape for functionality.
Alternatively, the functional signal could consist of an ex-
tended string or cluster of certain classes of residues. In
this regard, the high proportion of both acidic and hydrox-
ylated residues within both the 36-residue minimal signal
and the more inclusive 57-residue sequence is striking.
These are two of the three key sequence elements of
PEST sequences, a set of sequences that act as signals for
ubiquitination and consequent proteosomal turnover for
various short-lived cytoplasmic and nuclear proteins. The
third element of PEST sequences are prolines; there are
two prolines within the COOH-terminal 57 residues of
Ste3p, however, neither locate within the 414–449 interval.
PEST sequences are responsible for directing the ubiq-
uitin-dependent proteosomal degradation of a variety of
short-lived cytoplasmic and nuclear proteins (Rechsteiner
and Rogers, 1996). Though PEST sequences share no pri-
mary sequence identity to one another, they do share
overall character—protein sequences, 10–50-residues-long
containing unusually high densities of prolines, the acidic
residues glutamate and aspartate, and the hydroxylated
amino acids serine and threonine. The resemblance of the
STE3 signal to PEST sequences is consistent with the initi-
ating role that ubiquitin has been proposed to play in
Ste3p endocytosis (Roth and Davis, 1996). The STE3 sig-
nal may be first and foremost a signal for ubiquitination.
Recent work on two other yeast plasma membrane pro-
teins, the a-factor export protein Ste6p and the uracil per-
mease Fur4p, indicate that sequences similar to the STE3
signal likely participate in the uptake of these proteins as
well (Kolling and Losko, 1997; Marchal et al., 1998). Like
Ste3p, endocytosis and turnover of Ste6p and Fur4p also
appear to be ubiquitin dependent (Kolling and Hollen-
berg, 1994; Galan et al., 1996; Loaza and Michaelis, 1998).
For Ste6p, deletion of an acidic 61-residue sequence rich in
serines and threonines, abolished both Ste6p ubiquitina-
tion and its rapid turnover. Though this 61-residue-long
STE6 sequence was not sufficient to direct endocytosis of
a PMA1-STE6 fusion construct (equivalent in design to
the PMA1-STE3 constructs used herein), a larger, more
inclusive 108-residue sequence did suffice (Kolling and
Losko, 1997). Mutagenic studies on Fur4p, also demon-
Figure 9. Comparison of effects on turnover rate of mutants con-
structed in the Ste3D450-468p receptor versus the wild-type Ste3p
receptor context. Cells of strains isogenic to NDY334, except for
the transplacement of the wild-type STE3 by the indicated STE3
mutant allele, were subjected to a pulse-chase analysis equivalent
to that of Fig. 1. (A) Comparison of effects on turnover of two tri-
ple alanine mutations constructed either in the Ste3D450-468p
context (top panel) or in the wild-type Ste3p context (bottom
panel). The two triple alanine substitutions used for this experi-
ment replace either the 426–428 threonine-leucine-aspartate tri-
peptide or the 417–419 isoleucine-serine-leucine tripeptide. (B)
Comparison of the effects of the D441–450 deletion constructed
either in the Ste3D450-468p receptor context or in the wild-type
Ste3p context.The Journal of Cell Biology, Volume 142, 1998 960
strate the involvement of a sequence rich in acidic and hy-
droxylated residues in uptake and vacuolar degradation of
this permease (Marchal et al., 1998). These two sequences,
together with the STE3 sequence appear to constitute a
new class of endocytosis signal—a class where the primary
function of the signal may be to instigate ubiquitination.
Though resembling PEST sequences, these three ubiq-
uitination/endocytosis signals do not score strongly as
PEST sequences. This algorithm (Rogers et al., 1986) has
proved to be a powerful predictor of proteins subject to
rapid ubiquitin-dependent proteosomal turnover. None-
theless, as there is little direct molecular data concerning
the essential features of PEST sequences, the strictures of
this algorithm are necessarily somewhat arbitrary. The al-
gorithm examines only those sequences that are bounded
by basic residues (K, R, or H), and that include at least
one Pro, at least one acidic residue (D or E), and at least
one hydroxylated amino acid (S or T). Of these, the
strength of the resulting PEST score mostly depends on
the proportion of amino acids within the interval that are
either P, D, E, S, and T. The failure of the three ubiquiti-
nation/endocytosis signals to score strongly as PEST se-
quences reflects the paucity of proline residues within
these sequences. This could indicate either that the PEST
algorithm is overly stringent with regards to its proline re-
quirement, or more interestingly, a point of functional di-
vergence of these signals with PESTs. Although there ap-
pears to be significant overlap in the enzymatic machinery
catalyzing the ubiquitination of both proteosomal sub-
strates and cell surface proteins targeted for endocytosis
(see below), the ubiquitination requirements for these two
processes may be distinct. Where formation of a multi-
ubiquitin chain on the substrate is generally required for
proteosomal recognition (Hochstrasser, 1996), recent
work on the a-factor receptor indicates that the addition
of a single ubiquitin moiety suffices to direct endocytosis
(Terrell et al., 1998). One possibility, therefore, is that the
prolines present in the PEST sequences of proteosomal
substrates play a role in specifying the construction of the
multi-ubiquitin chain. In any case, as the relationship of
these new endocytosis signals to PEST sequences remains
uncertain, we perpetuate the term “PEST-like,” coined
by Marchal et al. (1998) in their description of the Fur4p
signal.
The 36-residue-long STE3 signal is the minimal se-
quence sufficient for ubiquitination and endocytosis.
PEST-like sequences in STE3, however, extend to the
COOH terminus and include in addition to the 36 residues
(414–449), the contiguous 21 COOH-terminal residues
(450–470). We have presented evidence that this COOH-
terminal sequence (450–470) may participate together in
redundant fashion with the 414–449 signal. Similar redun-
dancy may also apply within the minimal 414–449 interval.
Loss of function was gradual with extension of the dele-
tions into this interval. With extension of the deletion from
residue 450 to residue 447, the t1/2 increased from 25 to 40
min (Fig. 3, compare D450–468 and D447–468). With fur-
ther extension to residue 441 or to residue 434, the t1/2 in-
creased to 70 min (Fig. 3, D441–468 and D434–468). Only
deletions extending to residue 423 and residue 413 effec-
tively abolished endocytosis (Fig. 3, D423–468 and D413–
468). Thus it appears that both the rate of endocytosis, and
also the degree of ubiquitin modification (Fig. 3) reflects
the length of the PEST-like domain remaining in each mu-
tant. Functionality of the signal perhaps depends on its
overall size and on overall density of acidic and hydroxy-
lated residues. Larger, more negatively charged sequences
may provide better substrates for ubiquitination.
Negative charge within a potential ubiquitination/en-
docytosis signal could be further increased through the in-
troduction of phosphates. Such a model has been sug-
gested both for Fur4p endocytosis (Marchal et al., 1998)
and for the ligand-dependent endocytosis of Ste2p (Hicke
and Riezman, 1996; Hicke et al., 1998). Addition of acidic
phosphate moieties within an already acidic domain per-
haps elevates a sequence through some threshold barrier
of required negative charge density, allowing recognition
by the E3 ubiquitination machinery. For a number of
diverse proteosome substrates, phosphorylation within PEST
sequences often precedes and serves to instigate subse-
quent ubiquitination (Hochstrasser, 1996; Rechsteiner and
Rogers, 1996). This may be true for Ste3p as well, as it
clearly is subject to phosphorylation (Roth and Davis,
1996).
In terms of potential ubiquitin acceptor sites, Ste3p has
a total 23 cytoplasmically available lysine residues. Three
map within the COOH-terminal 57-residue PEST-like se-
quence and of these, two within the 36-residue minimal
signal. The disabling effect of the triple alanine mutation
of residues 432–434 (Fig. 8) suggested the possibility that
Lys432 might serve as the sole ubiquitin acceptor site
within the D450–468 receptor. However, this is not sup-
ported by the effects of a K432R point mutation. Within
the context of the D450–468 receptor, this mutation failed
to block receptor ubiquitination and showed only an inter-
mediate turnover disability (t1/2 5 60 min; data not shown).
Possibilities currently being tested are either that the ubiq-
uitination occurs at lysines mapping outside of the PEST-
like sequence and/or that multiple lysines are used redun-
dantly.
The endocytosis signal characterized herein is also a
ubiquitination signal. While decoding this signal could in-
volve the binding of the adaptins and coat proteins, it
seems more likely that initial interactions are with en-
zymes that catalyze ubiquitin addition. Generally for ubiq-
uitination, although the precise biochemical or genetic re-
quirements are incompletely understood, it is clear that
the E2 and E3 classes of enzymes participate both in rec-
ognizing the substrate protein and in the subsequent ubiq-
uitin transfer (Hochstrasser, 1996). For Ste3p ubiquiti-
nation, there are several E2 and E3 candidates. A
component of the E3 complex could be the hect-domain
protein Rsp5p. Though involvement in pheromone recep-
tor endocytosis remains to be determined, RSP5 is re-
quired for the ubiquitination and endocytic turnover of
several different yeast plasma membrane proteins (Hein
et al., 1995; Lucero and Lagunas, 1997). In terms of partic-
ipating E2 functions, the redundant enzymes Ubc4p and
Ubc5p, as well as Ubc1p are likely involved as they have
been implicated in the ubiquitination and endocytosis for
a variety yeast plasma membrane proteins (Kolling and
Hollenberg, 1994; Egner and Kuchler, 1996; Hicke and
Riezman, 1996; Roth and Davis, 1996). These E2 and E3
activities, however, can not be exclusively devoted toRoth et al. Ubiquitin-directed Endocytosis 961
plasma membrane protein turnover. Rsp5p, Ubc4p, and
Ubc5p also are required for the ubiquitination and proteo-
somal turnover of a variety of short-lived cytoplasmic and
nuclear proteins (Hochstrasser, 1996). In addition, Rsp5p
recently has been implicated as a participant in the mito-
chondrial import process (Zolladek et al., 1997). Thus,
these enzymes participate in a number of quite distinct cel-
lular processes occurring at a number of distinct cellular
sites. Specificity for membrane proteins will likely also in-
volve the inclusion of other, presently unknown factors
into these E2 and E3 complexes to direct both cellular lo-
calization and proper substrate recognition. A goal for the
future, then, is to identify the specific factors that bind to
and decode this new class of ubiquitination/endocytosis
signal.
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